Unlike genes like TP53, EGFR and PTEN which carry mutations in high proportion of GBM tumor samples (34%, 33% and 39% respectively) [11], RBPs are mutated in lesser proportion of tumor samples. This evidence concerns the gene PTEN and glioblastoma.